Current through Bulletin 2024-20, October 15, 2024
Section R156-17b-621a - Operating Standards - Pharmacist Administration of a Long-acting Injectable and Naloxone - TrainingIn accordance with Subsections 58-17b-502(1)(i) and 58-17b-625(2):
(1) Prior to engaging in the administration of a long-acting injectable drug pursuant to Section 58-17b-625, a pharmacist shall successfully complete: (a) current Basic Life Support (BLS) certification; and(b) a training program for administering long-acting injectables intramuscularly that is provided by an ACPE-accredited provider.(2) An individual who engages in the administration of long-acting injectable drugs intramuscularly shall maintain documentation that they obtained their required training.Utah Admin. Code R156-17b-621a
Adopted by Utah State Bulletin Number 2018-1, effective 12/12/2017Amended by Utah State Bulletin Number 2019-24, effective 11/25/2019Amended by Utah State Bulletin Number 2022-03, effective 1/27/2022